Doris Benbrook to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Doris Benbrook has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.849
-
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. Int J Cancer. 2020 08 15; 147(4):1086-1097.
Score: 0.681
-
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. J Med Chem. 1999 Oct 21; 42(21):4434-45.
Score: 0.168